Callan Family Office LLC Takes $249,000 Position in Omega Healthcare Investors, Inc. $OHI

Callan Family Office LLC acquired a new position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 6,798 shares of the real estate investment trust’s stock, valued at approximately $249,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. grew its position in Omega Healthcare Investors by 3.9% in the first quarter. Vanguard Group Inc. now owns 39,554,886 shares of the real estate investment trust’s stock worth $1,506,250,000 after acquiring an additional 1,492,904 shares during the period. Charles Schwab Investment Management Inc. lifted its stake in shares of Omega Healthcare Investors by 2.9% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 4,100,891 shares of the real estate investment trust’s stock valued at $156,162,000 after purchasing an additional 114,665 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Omega Healthcare Investors by 4.3% during the 1st quarter. Dimensional Fund Advisors LP now owns 4,058,107 shares of the real estate investment trust’s stock worth $154,533,000 after purchasing an additional 165,554 shares during the period. Bank of New York Mellon Corp increased its position in shares of Omega Healthcare Investors by 6.4% during the 1st quarter. Bank of New York Mellon Corp now owns 3,123,152 shares of the real estate investment trust’s stock worth $118,930,000 after purchasing an additional 188,481 shares during the last quarter. Finally, AQR Capital Management LLC raised its holdings in Omega Healthcare Investors by 430.8% in the 1st quarter. AQR Capital Management LLC now owns 2,862,117 shares of the real estate investment trust’s stock valued at $108,989,000 after buying an additional 2,322,878 shares during the period. 65.25% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of the company’s stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $40.16, for a total value of $100,400.00. Following the sale, the director owned 18,654 shares in the company, valued at approximately $749,144.64. This represents a 11.82% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.50% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several research firms have weighed in on OHI. Wells Fargo & Company lifted their target price on Omega Healthcare Investors from $41.00 to $44.00 and gave the company an “overweight” rating in a research report on Wednesday, August 27th. Truist Financial lifted their price objective on shares of Omega Healthcare Investors from $39.00 to $44.00 and gave the company a “hold” rating in a report on Wednesday, September 3rd. Cantor Fitzgerald started coverage on shares of Omega Healthcare Investors in a research note on Wednesday, October 1st. They set an “overweight” rating and a $50.00 target price on the stock. Mizuho raised their price target on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the company a “neutral” rating in a research report on Thursday, September 11th. Finally, Scotiabank boosted their price target on shares of Omega Healthcare Investors from $39.00 to $42.00 and gave the stock a “sector perform” rating in a research note on Thursday, August 28th. Seven research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $44.44.

Omega Healthcare Investors Trading Up 0.7%

NYSE:OHI opened at $40.37 on Friday. The stock has a fifty day moving average price of $41.56 and a two-hundred day moving average price of $38.86. The stock has a market capitalization of $11.91 billion, a price-to-earnings ratio of 24.92, a PEG ratio of 1.87 and a beta of 0.70. The company has a debt-to-equity ratio of 0.96, a quick ratio of 7.10 and a current ratio of 7.10. Omega Healthcare Investors, Inc. has a 1 year low of $35.04 and a 1 year high of $44.42.

Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.45 by $0.32. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The company had revenue of $235.60 million for the quarter, compared to analysts’ expectations of $248.49 million. During the same period last year, the company earned $0.71 EPS. The firm’s revenue for the quarter was up 11.8% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. As a group, sell-side analysts anticipate that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Monday, August 4th were issued a dividend of $0.67 per share. The ex-dividend date was Monday, August 4th. This represents a $2.68 annualized dividend and a yield of 6.6%. Omega Healthcare Investors’s payout ratio is currently 165.43%.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.